Tag: diabetes treatment
-
Trump Administration Secures Deal to Lower GLP-1 Drug Prices for Medicare and Other Americans
Trump Administration Negotiates Lower GLP-1 Prices The Trump administration announced new price relief for GLP-1 medications, a class of diabetes and weight-loss drugs that has drawn sharp attention for its rising costs. Through negotiations with pharmaceutical giants Novo Nordisk and Eli Lilly, the administration outlined deals intended to reduce out-of-pocket expenses for Medicare beneficiaries and…
-
Ozempic Sober: What GLP-1 Medications Could Mean for Alcohol Intoxication
What “Ozempic sober” means Recent research has sparked discussion about a possible new effect of GLP-1 receptor agonists, a class of drugs that includes Ozempic (semaglutide). The term “Ozempic sober” has surfaced in media coverage to describe a potential change in how the body processes and experiences alcohol while on these medications. Early signals from…
-
WHO Updates Essential Medicines List Including GLP-1s
Introduction to WHO’s Essential Medicines List The World Health Organization (WHO) is renowned for its ongoing commitment to global health and well-being. One of its key initiatives is the Model List of Essential Medicines (EML), which outlines the necessary medications for addressing the most critical health needs across populations. Recently, the WHO has updated this…
-
Mounjaro Users Face Reduction in Dosage and Increased Costs
The Recent Changes to Mounjaro: What You Need to Know In a surprising announcement, Eli Lilly, the manufacturer of the popular weight loss medication Mounjaro, has confirmed significant changes to its KwikPen delivery system that are causing concern among users. As of now, Mounjaro users will receive less of the drug for their money, compounding…